Nektar Therapeutics (NASDAQ:NKTR) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...
The Manila Times53m
Solar A/S: No. 4 2025 Course of annual general meeting
The annual general meeting (AGM) took due note of the management's review and discussed and approved the Annual Report 2024 together with the statement by the Executive Board and the Board of ...